Immunology Market In Europe And North America
I am putting together a market study on 'north america & europe immunology market'.
As a part of my validation process, i am looking to share my findings, market estimates, forecasts and market insights with an expert in the field. I would require a short 15 mins interview with an industry expert, who has expertise in the commercial and market aspects of the following segments.
Immunology diseases: ankylosing spondylitis, crohn’s disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ulcerative colitis
types of drugs: glucocorticoids/nsaids, non-biologic disease modifying drugs (dmards) & biologics
cimzia (certolizumab pegol)
copaxone (glatiramer acetate)
glatopa (glatiramer acetate)
the expert could be a product manager, marketing manager who has previously worked in the marketing of these drugs. It could also be biopharmaceutical consultants, market research experts, scientists who work closely with the products at a commercial level.
Please feel free to get in touch with me if you qualify the above requirements.
annette+undefined Other Responses
Biologic Shipping Validation
If the shipping validation of a fda approved biologic manufactured overseas has been successfully completed from site of manufacture to a 3pl to a distributor, and now the 3pl will change, does the validation need to be repeated?+undefined Other Responses
Central Laboratory Testing
We are looking for experts specific to "central laboratory testing" for vaccine clinical trials who can answer on the below mentioned topics
1) market scenario - market size, top players with market shares
2) changing supplier landscape and the impact on buyers
3) deep dive information on - q2 solutions, ppd and covance (strengths and weakness with in central lab testing)+9 Other Responses